Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q1 2026 Earnings Call Transcript

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q1 2026 Earnings Call Transcript April 29, 2026

Regeneron Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $9.47, expectations were $8.91.

Operator: Welcome to the Regeneron Pharmaceuticals First Quarter 2026 Earnings Conference Call. My name is Kevin, and I’ll be your operator for today’s call. [Operator Instructions] Please note this conference is being recorded. I will now turn the call over to Ryan Crowe, Senior Vice...